Rapid identification of preformed alloreactive T cells for use in a clinical setting

Transplantation

Volumn 78, Issue 4, 2004, Pages 607-614

  Sester, Urban ^a   Thijssen, Stephan ^a   Van Bentum, Kai ^a   Neumann, Frank ^a   Kubuschok, Boris ^a   Sester, Martina ^a   Köhler, Hans ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Chronic; Complications of clinical transplantation; Crossmatching; Histocompatibility (clinical and experimental); Immunologic methods; Immunologic monitoring; T cell activation; Tissue typing; Transplantation immunology and immunobiology

Indexed keywords

ANTIBODY; BREFELDIN A; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CYTOKINE; FLUORESCEIN ISOTHIOCYANATE; HLA A ANTIGEN; HLA B ANTIGEN;

ADULT; AGED; ALLOIMMUNITY; ALLOREACTIVE T CELL; ARTICLE; BYSTANDER EFFECT; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MALE; OUTCOMES RESEARCH; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 4143060395     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000131949.59284.4D     Document Type: Article

References (36)

1. Heeger PS. T-cell allorecognition and transplant rejection: a summary and update. Am J Transplant 2003; 3: 525.
2. + T-cell memory, CD45R subsets and the persistence of antigen: a unifying concept. Immunol Today 1998; 19: 60.
3. Brehm MA, Markees TG, Daniels KA, et al. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections. J Immunol 2003; 170: 4077.
4. Lombardi G, Sidhu S, Daly M, et al. Are primary alloresponses truly primary. Int Immunol 1990; 2: 9.
5. Opelz G. HLA matching should be utilized for improving kidney transplant success rates. Transplant Proc 1991; 23: 46.
6. Opelz G, Schwarz V, Engelmann A, et al. Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients. Transplant Proc 1991; 23: 373.
7. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605.
8. Heeger PS, Greenspan NS, Kuhlenschmidt S, et al. Pretransplant frequency of donor-specific, IFN-[gamma]-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163: 2267.
9. Sester M, Sester U, Gärtner B, et al. Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus. J Virol 2002; 76: 3748.
10. Sester M, Sester U, Gärtner B, et al. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation 2001; 71: 1287.
11. Kubuschok B, Schmits R, Hartmann F, et al. Use of spontaneous Epstein-Barr virus-lymphoblastoid cell lines genetically modified to express tumor antigen as cancer vaccines: mutated p21 ras oncogene in pancreatic carcinoma as a model. Hum Gene Ther 2002; 13: 815.
12. Karisson AC, Martin JN, Younger SR, et al. Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells. J Immunol Methods 2003; 283: 141.
13. Matesic D, Lehmann PV, Heeger PS. High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice. Transplantation 1998; 65: 906.
14. Dallman MJ. Cytokines and transplantation: Th1/Th2 regulation of the immune response to solid organ transplants in the adult. Curr Opin Immunol 1995; 7: 632.
15. Najafian N, Salama AD, Fedoseyeva EV, et al. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 2002; 13: 252.
16. Sester M, Sester U, Alarcon Salvador S, et al. Age-related decrease in adenovirus-specific T cell responses. J Infect Dis 2002; 185: 1379.
17. Sester M, Gärtner BC, Sester U, et al. Is the CMV serologic status always accurate? A comparative analysis of humoral and cellular immunity. Transplantation 2003; 76: 1229.
18. Sester M, Sester U, Clauer P, et al. Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int 2004; 65: 1826.
19. Herzog WR, Zanker B, Irschick E, et al. Selective reduction of donor-specific cytotoxic T lymphocyte precursors in patients with a well-functioning kidney allograft. Transplantation 1987; 43: 384.
20. de Haan A, van den Berg AP, van der Bij W, et al. Rapid decreases in donor-specific cytotoxic T lymphocyte precursor frequencies and graft outcome after liver and lung transplantation. Transplantation 2001; 71: 785.
21. Mestre M, Massip E, Bas J, et al. Longitudinal study of the frequency of cytotoxic T cell precursors in kidney allograft recipients. Clin Exp Immunol 1996; 104: 108.
22. Liu Z, Colovai AI, Tugulea S, et al. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest 1996; 98: 1150.
23. Ng WF, Hernandez-Fuentes M, Baker R, et al. Reversibility with interleukin-2 suggests that T cell anergy contributes to donor-specific hyporesponsiveness in renal transplant patients. J Am Soc Nephrol 2002; 13: 2983.
24. Dallman MJ, Roake J, Hughes D, et al. Sequential analysis of IL-2 gene transcription in renal transplants. Transplantation 1992; 53: 683.
25. Suthanthiran M. Molecular analyses of human renal allografts: differential intragraft gene expression during rejection. Kidney Int Suppl 1997; 58: S15.
26. Chung SW, Yoshida EM, Cattral MS, et al. Donor-specific stimulation of peripheral blood mononuclear cells from recipients of orthotopic liver transplants is associated, in the absence of rejection, with type-2 cytokine production. Immunol Lett 1998; 63: 91.
27. De Haan A, Van Der Gun I, Van Der Bij W, et al. Detection of alloreactive T cells by flow cytometry: a new test compared with limiting dilution assay. Transplantation 2002; 74: 562.
28. Paglieroni TG, Perez R, Katznelson S, et al. Donor cell induced CD69 expression and intracellular IL-2 and IL-4 production by peripheral blood lymphocytes isolated from kidney transplant recipients. Hum Immunol 1999; 60: 41.
29. Gebauer BS, Hricik DE, Atallah A, et al. Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant 2002; 2: 857.
30. Baxter-Lowe LA, Eckels DD, Ash R, et al. The predictive value of HLA-DR oligotyping for MLC responses. Transplantation 1992; 53: 1352.
31. Santamaria P, Reinsmoen NL, Lindstrom AL, et al. Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs. Blood 1994; 83: 280.
32. Mendoza LM, Paz P, Zuberi A, et al. Minors held by majors: the H13 minor histocompatibility locus defined as a peptide/MHC class I complex. Immunity 1997; 7: 461.
33. Berger M, Wettstein PJ, Korngold R. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens. Transplantation 1994; 57: 1095.
34. Lechler RI, Heaton T, Barber L, et al. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses. Immunol Lett 1992; 34: 63.
35. Thomson AW, Mazariegos GV, Reyes J, et al. Monitoring the patient off immunosuppression: conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation 2001; 72: S13.
36. Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003; 361: 1502.